Synairgen plc

AIM:SNG 주식 보고서

시가총액: UK£9.6m

Synairgen 관리

관리 기준 확인 4/4

Synairgen's CEO is Richard Marsden, appointed in Sep 2009, has a tenure of 15.17 years. total yearly compensation is £328.00K, comprised of 94.5% salary and 5.5% bonuses, including company stock and options. directly owns 0.49% of the company’s shares, worth £47.45K. The average tenure of the management team and the board of directors is 3.8 years and 8.7 years respectively.

주요 정보

Richard Marsden

최고 경영자

UK£328.0k

총 보상

CEO 급여 비율94.5%
CEO 임기15.2yrs
CEO 소유권0.5%
경영진 평균 재임 기간3.8yrs
이사회 평균 재임 기간8.7yrs

최근 관리 업데이트

Recent updates

Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

Dec 09
Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

Here's Why We're Watching Synairgen's (LON:SNG) Cash Burn Situation

Aug 24
Here's Why We're Watching Synairgen's (LON:SNG) Cash Burn Situation

Is Synairgen (LON:SNG) In A Good Position To Invest In Growth?

Apr 29
Is Synairgen (LON:SNG) In A Good Position To Invest In Growth?

Companies Like Synairgen (LON:SNG) Could Be Quite Risky

Dec 27
Companies Like Synairgen (LON:SNG) Could Be Quite Risky

We're A Little Worried About Synairgen's (LON:SNG) Cash Burn Rate

Sep 13
We're A Little Worried About Synairgen's (LON:SNG) Cash Burn Rate

Companies Like Synairgen (LON:SNG) Could Be Quite Risky

May 31
Companies Like Synairgen (LON:SNG) Could Be Quite Risky

Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

Feb 06
Here's Why We're Not Too Worried About Synairgen's (LON:SNG) Cash Burn Situation

We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

Oct 21
We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

Mar 29
We're Hopeful That Synairgen (LON:SNG) Will Use Its Cash Wisely

How Much Of Synairgen plc (LON:SNG) Do Institutions Own?

Dec 14
How Much Of Synairgen plc (LON:SNG) Do Institutions Own?

CEO 보상 분석

Richard Marsden 의 보수는 Synairgen 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-UK£7m

Mar 31 2024n/an/a

-UK£8m

Dec 31 2023UK£328kUK£310k

-UK£8m

Sep 30 2023n/an/a

-UK£9m

Jun 30 2023n/an/a

-UK£10m

Mar 31 2023n/an/a

-UK£14m

Dec 31 2022UK£328kUK£310k

-UK£18m

Sep 30 2022n/an/a

-UK£23m

Jun 30 2022n/an/a

-UK£28m

Mar 31 2022n/an/a

-UK£38m

Dec 31 2021UK£1mUK£256k

-UK£49m

Sep 30 2021n/an/a

-UK£46m

Jun 30 2021n/an/a

-UK£43m

Mar 31 2021n/an/a

-UK£28m

Dec 31 2020UK£415kUK£194k

-UK£14m

Sep 30 2020n/an/a

-UK£10m

Jun 30 2020n/an/a

-UK£6m

Mar 31 2020n/an/a

-UK£5m

Dec 31 2019UK£289kUK£190k

-UK£4m

Sep 30 2019n/an/a

-UK£4m

Jun 30 2019n/an/a

-UK£4m

Mar 31 2019n/an/a

-UK£3m

Dec 31 2018UK£205kUK£186k

-UK£3m

Sep 30 2018n/an/a

-UK£898k

Jun 30 2018n/an/a

UK£2m

Mar 31 2018n/an/a

UK£2m

Dec 31 2017UK£336kUK£182k

UK£2m

보상 대 시장: Richard's total compensation ($USD423.80K) is about average for companies of similar size in the UK market ($USD369.83K).

보상과 수익: Richard's compensation has been consistent with company performance over the past year.

CEO

Richard Marsden (57 yo)

15.2yrs

테뉴어

UK£328,000

보상

Mr. Richard Marsden has been Chief Executive Officer of Synairgen Research Ltd since September 2009. Mr. Marsden has been Managing Director and Executive Director at Synairgen since June 2004 has been its...

리더십 팀

이름위치테뉴어보상소유권
Richard Marsden
CEO, MD & Executive Director15.2yrsUK£328.00k0.49%
£ 47.4k
Stephen Holgate
Co-Founderno dataUK£40.00k0.45%
£ 43.5k
Joseph Colliver
CFO & Executive Directorless than a yearUK£197.41k데이터 없음
Phillip Monk
Chairman of Scientific Advisory Board15.2yrsUK£241.00k0.21%
£ 20.2k
Donna Davies
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Ratko Djukanovic
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Gareth Walters
Chief Regulatory Officer3.1yrs데이터 없음데이터 없음
Jody Brookes
Senior VP & Head of Clinical Operations12.9yrs데이터 없음데이터 없음
Richard Francis
Senior VP and Head of CMC & Quality3.2yrs데이터 없음데이터 없음
Victoria Tear
Head of Laboratory5.6yrs데이터 없음데이터 없음
Marcin Mankowski
Chief Medical Officer1.1yrs데이터 없음데이터 없음
Simon Holden
Company Secretary3.8yrs데이터 없음데이터 없음

3.8yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: SNG's management team is considered experienced (3.8 years average tenure).

이사회 구성원

이름위치테뉴어보상소유권
Richard Marsden
CEO, MD & Executive Director20.4yrsUK£328.00k0.49%
£ 47.4k
Stephen Holgate
Co-Founder21.4yrsUK£40.00k0.45%
£ 43.5k
Joseph Colliver
CFO & Executive Directorless than a yearUK£197.41k데이터 없음
Phillip Monk
Chairman of Scientific Advisory Board15.2yrsUK£241.00k0.21%
£ 20.2k
Donna Davies
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Ratko Djukanovic
Co-Founder & Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Mark Parry-Billings
Chairmanless than a year데이터 없음데이터 없음
David Campbell
Non-Executive Director & Member of Scientific Advisory Board18.6yrsUK£40.00k0.16%
£ 15.8k
Felicity Gabbay
Member of Scientific Advisory Board & Independent Non-Executive Director2.2yrsUK£45.00k데이터 없음
Amanda Radford
Independent Non-Executive Director1.9yrsUK£45.00k데이터 없음

8.7yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: SNG's board of directors are considered experienced (8.7 years average tenure).